ElmediX aims to extend the lives of cancer patients and to improve their quality of life. Initially our focus is on pancreatic cancer, but other cancer types are also being investigated.
ElmediX’s thermal therapy is a treatment in which the body temperature is raised to 41.5ºC for a certain period of time.
Clinical research has shown that thermal therapy can have a positive outcome in the treatment of cancer.
Warming the body up to 41.5ºC (thermal therapy) for several hours strengthens the immune system, kills cancer cells, increases the absorption of chemotherapeutics and makes cancer cells more sensitive to radiation.
The test results are promising and align to the company mission. Together with healthcare providers and investors, we strive to extend the lives of cancer patients and improve their quality of life.